Contraception and fertility plans in a cohort of HIV-positive women in care

Contraception

Volumn 75, Issue 4, 2007, Pages 294-298

  Stanwood, Nancy L ^a   Cohn, Susan E ^a   Heiser, Jennifer R ^b   Pugliese, MaryAnn ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

AIDS; Antiretroviral; Contraception; HIV; Tubal ligation

Indexed keywords

ANTIRETROVIRUS AGENT; CONTRACEPTIVE AGENT; HORMONE; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; SPERMICIDAL AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; ATTITUDE TO PREGNANCY; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; CONTRACEPTION; FEMALE; FEMALE FERTILITY; FEMALE STERILIZATION; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RELATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MEDICAL RECORD; MONOGAMY; ORAL CONTRACEPTION; PREGNANCY; REPRODUCTIVE HEALTH; SEXUAL BEHAVIOR; WOMEN'S HEALTH;

ADOLESCENT; ADULT; COHORT STUDIES; CONTRACEPTION BEHAVIOR; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE DEVICES; FEMALE; FERTILITY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREGNANCY; STERILIZATION, TUBAL;

EID: 33847779472     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2006.12.012     Document Type: Article

References (19)

1. UNAIDS. AIDS epidemic update. World Health Organization. 2006 report on the global AIDS epidemic Annex 2: HIV/AIDS estimates and data (2005). http://www.unaids.org/en/HIV_data/2006GlobalReport/assessed9/23/06
2. Anastos K., Barron Y., Cohen M.H., et al. The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy. Ann Intern Med 140 (2004) 256-264
3. Anastos K., Barron Y., Miotti P., et al. Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease. Arch Intern Med 162 (2002) 1973-1980
4. Egger M., May M., Chene G., et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 360 (2002) 119-129 [erratum 2002;360:1178]
5. R.S. Hogg, K.V. Heath, B. Yip, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 1998; 279 6: 450-454.
6. S.Y. Chu, J.W. Buehler, R.L. Berkelman, Impact of the human immunodeficiency virus epidemic on mortality in women of reproductive age, United States. JAMA 1990; 264 2: 225-229.
7. R. Rothenberg, M. Woelfel, R. Stoneburner, et al. Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. N Engl J Med 1987; 317 21: 1297-1302.
8. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents - October 6, 2005. 2005 [cited March 2006]. Available from: (May 4, 2006). http://www.aidsinfo.nih.gov/guidelines/GuidelineDetail.aspx?MenuItem=Gui delines&Search=Off&GuidelineID=7&ClassID=1 [assessed 9/23/06]
9. Kanouse D.E., Collins R.L., Miu A., and Berry S.H. HIV-infected population national data. J Acquir Immune Defic Syndr 38 Suppl 1 (2005) S6-S7
10. J.L. Chen, K.A. Philips, D.E. Kanouse, R.L. Collins, A. Miu. Fertility desires and intentions of HIV-positive men and women. Fam Plann Perspec 2001;33:144-152, 65.
11. Bedimo A.L., Bessinger R., and Kissinger P. Reproductive choices among HIV-positive women. Soc Sci Med 46 (1998) 171-179
12. J.M. Stephenson, A. Griffioen. The effect of HIV diagnosis on reproductive experience. Study Group for the Medical Research Council Collaborative Study of Women with HIV. AIDS 1996; 10 14: 1683-1687.
13. Company B-MS. Important change in SUSTIVA® (efavirenz) package insert - change from pregnancy category C to D. 2004 cited; Available from:. www.fda.gov/medwatch/SAFETY/2005/Sustiva_DHCPletter-061005.pdf
14. S.K. Henshaw. Unintended pregnancy in the United States. Fam Plann Perspect 1998; 30 1: 24-9.
15. Mosher W.D., Martinez G., Chandra A., Abma J., and Willson S. Use of contraception and use of family planning services in the United States, 1982-2002 (2004), National Center for Health Statistics, Bethesda MD
16. S.D. Hillis, P.A. Marchbanks, L.R. Tylor, H.B. Peterson, Poststerilization regret: findings from the United States Collaborative Review of Sterilization. Obstet Gynecol 1999; 93 6: 889-895.
17. J.H. Chu, S.J. Gange, K. Anastos, et al. Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy. Am J Epidemiol 2005; 161 9: 881-890.
18. S.K. Sinei, C.S. Morrison, C. Sekadde-Kigondu, M. Allen, D. Kokonya, Complications of use of intrauterine devices among HIV-1-infected women. Lancet 1998; 351 9111: 1238-1241.
19. WHO. Selected practice recommendations for contraceptive use (2004), World Health Organization, Department of Reproductive Health and Research, Geneva